Full-length MAVS, a mitochondrial antiviral-signaling protein, inhibits hepatitis E virus replication, requiring JAK-STAT signaling

Changbo Qu, Yang Li, Yunlong Li, Yihang Pan*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Hepatitis E virus (HEV) infection is the leading cause of acute hepatitis worldwide. The mitochondrial antiviral signaling protein (MAVS)-mediated interferon (IFN) response plays a pivotal role in hepatic antiviral immunity. However, little is known about the effect of overexpression of MAVS on HEV infection. Full-length MAVS (FL-MAVS) is the main form of MAVS that increases the production of IFNs. Here, we studied the effect of FL-MAVS on HEV infection. We found that overexpression of FL-MAVS profoundly inhibited HEV replication. Furthermore, we showed that the anti-HEV effect of FL-MAVS is largely dependent on JAK-STAT signaling activation.

Original languageEnglish
Pages (from-to)1293-1300
Number of pages8
JournalArchives of Virology
Volume167
Issue number5
DOIs
Publication statusPublished - May 2022

Bibliographical note

Acknowledgements
This research was supported by the research start-up fund of the Seventh Affiliated Hospital Sun Yat-sen University (SAHSYSU) (ZSQYRSFPD0028) to C. Qu.

Publisher Copyright: © 2022, The Author(s).

Fingerprint

Dive into the research topics of 'Full-length MAVS, a mitochondrial antiviral-signaling protein, inhibits hepatitis E virus replication, requiring JAK-STAT signaling'. Together they form a unique fingerprint.

Cite this